Manuel Rieber
Caracas, A 1020, Bolivarian Republic of Venezuela
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Cancer Pro-oxidant Therapy Through Copper Redox Cycling: Repurposing Disulfiram and Tetrathiomolybdate.
Journal: Current pharmaceutical design
Published: March 02, 2020
Nitroprusside induces melanoma ferroptosis with serum supplementation and prolongs survival under serum depletion or hypoxia.
Journal: Biochemical and biophysical research communications
Published: January 21, 2020
Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS/BRAF mutations and c-MYC/p53 status.
Journal: Ecancermedicalscience
Published: August 14, 2018
Optimized Multiplex Detection of 7 KRAS Mutations by Taqman Allele-Specific qPCR.
Journal: PloS one
Published: July 11, 2016
Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.
Journal: Oncotarget
Published: June 09, 2015
p53 inactivation decreases dependence on estrogen/ERK signalling for proliferation but promotes EMT and susceptility to 3-bromopyruvate in ERα+ breast cancer MCF-7 cells.
Journal: Biochemical pharmacology
Published: December 06, 2013
Hypoxia and hypoxia mimetic cooperate to counteract tumor cell resistance to glucose starvation preferentially in tumor cells with mutant p53.
Journal: Biochemical and biophysical research communications
Published: November 12, 2013
Hypoxia, Mn-SOD and H(2)O(2) regulate p53 reactivation and PRIMA-1 toxicity irrespective of p53 status in human breast cancer cells.
Journal: Biochemical pharmacology
Published: July 09, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026